أخبار سوق الأسهم
آخر الأخبار المالية · محدّث مايو 23, 2026
تويتر يحتفل بالذكرى الخمسين لشركة أبل: من شركة гараج بقيمة 3.73 تريليون دولار - إليك مقدار ما كانت ستكسب استثمارًا بقيمة 1000 دولار في تاريخ إدراجها
Apple Turns 50: From Garage Startup To $3.73 Trillion Giant—Here's How Much A $1,000 Investment At Its IPO Would Be Worth Today
The panelists generally agreed that Apple's current valuation and future growth prospects are uncertain, with significant risks and opportunities ahead.
ChatGPT يشرح لي الإيثيريوم وكأنني في الثانية عشرة من عمري
I Asked ChatGPT To Explain Ethereum to Me Like I’m 12
The panel discussion on Ethereum's investment thesis highlights significant competition from other chains, regulatory risks, and the need for further …
كير ستارميلد، أي شخص؟ هل سيتعين إعادة تسمية المربى في المملكة المتحدة حقًا؟
Keir Starmalade, anyone? Will marmalade really have to be rebranded in UK?
The panel generally agrees that the marmalade labeling change is a non-event for major UK food companies, with some long-term …
'ليس تمامًا جريجز': منشئو TikTok يختبرون مخابز لندن "المُحسَّنة"
‘Not quite Greggs’: TikTok creators put London’s ‘gentrified’ bakeries to the test
The panel's net takeaway is that while these premium-priced, artisanal bakeries benefit from TikTok-driven visibility, their long-term resilience and profitability …
تقوم Goldman Sachs برفع هدفها السعري لـ PVH Corp. (PVH) إلى 93 دولارًا من 83 دولارًا.
Goldman Sachs Raises its Price Target on PVH Corp. (PVH) to $93 from $83
The panelists had a mixed view on PVH's outlook, with some flagging risks like EMEA softness, reliance on margin expansion, …
Ascendis Pharma A/S (ASND) تُعلن عن بيانات الأسبوع 52 الإيجابية من المرحلة 2 لدراسة InsiGHTS الجديدة
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
The panel discusses ASND's Week 52 Phase 2 data showing TransCon hGH's non-inferiority to daily somatropin, with YUVIWEL's EMA approval …
وولف ريسيرش تبدأ تغطية BeOne Medicines AG (ONC) بتصنيف Outperform
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
The panel is neutral on BeOne Medicines (ONC), with concerns about Brukinsa's long-term margins due to generic competition and uncertainty …
ميزوهو تخفض السعر المستهدف لشركة Autolus Therapeutics plc (AUTL) إلى 10 دولارات من 12 دولارًا
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12
The panelists debated AUTL's outlook, with some highlighting its strong Q4 results and potential for 2026 inflection, while others raised …
Galapagos NV (GLPG) توقع اتفاقية مع Gilead بشأن أصول الأدوية Ouro
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
GLPG's partnership with Gilead on gamgertamig provides a pipeline extension and potential near-to-mid-term catalyst, but the deal's true value lies …
RBC Capital تخفض السعر المستهدف لسهم Bicycle Therapeutics plc (BCYC) إلى 7 دولارات من 11 دولارًا
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
BCYC's one-time revenue from terminated partnerships masks a pivot away from zelenectide due to regulatory feedback, reducing near-term commercialization visibility. …
أفضل صناديق الاستثمار المتداولة للنفط بسعر 100 دولار للشراء الآن
The Best ETFs For $100 Oil To Buy Right Now
The panel consensus is that while $105 WTI is driven by geopolitical risks, it may not be sustained due to …
TD Cowen ترفع سعرها المستهدف لسهم Marex Group plc (MRX) إلى 66 دولارًا من 61 دولارًا
TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61
Panelists are divided on Marex Group (MRX). Bulls highlight record revenue beats and potential re-rating, while bears question the sustainability …